Intravenous low-dose native tissue plasminogen activator for distal embolism in the middle cerebral artery divisions or branches: A pilot study

Neurosurgery

Volumn 46, Issue 4, 2000, Pages 853-859

  Nakano, Shinichi ^a   Iseda, Tsutomu ^a   Yoneyama, Takumi ^a,b   Ikeda, Tokuro ^b   Wakisaka, Shinichiro ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b Junwakai Memorial Hospital   (Japan)

Author keywords

Cerebral; Embolism; Ischemia; Middle cerebral artery; Plasminogen activator; Thrombolytic therapy; Tissue type

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN EMBOLISM; BRAIN ISCHEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; PRIORITY JOURNAL; STROKE;

EID: 0034118218     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/00006123-200004000-00016     Document Type: Article

References (20)

1. Baron JC, von Kummer R, del Zoppo GJ: Treatment of acute ischemic stroke: Challenging the concept of a rigid and universal time window. Stroke 26:2219-2221, 1995.
2. Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R, Marler JR: Urgent therapy for stroke: Part I - Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 23:632-640, 1992.
3. Dalal PM, Shah PM, Sheth SC, Deshpande CK: Cerebral embolism: Angiographic observations on spontaneous clot lysis. Lancet 1:61-64, 1965.
4. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee R Jr, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM: Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32:78-86, 1992.
5. Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L: Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 91:311-322, 1989.
6. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, Hennerici MG for the ECASS Study Group: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017-1025, 1995.
7. Haley EC Jr, Levy DE, Brott TG, Sheppard GL, Wong MCW, Kongable GL, Torner JC, Marler JR: Urgent therapy for stroke: Part II - Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke 23:641-645, 1992.
8. Kamiya K, Yoshida N, Okada K, Watanabe E: Affinity to fibrin and binding to PAI - 1 of tissue-type plasminogen activator preparations (2). Jpn Pharmacol Ther 24:795-798, 1996.
9. Larrue V, von Kummer R, del Zoppo GJ, Bluhmki E: Hemorrhagic transformation in acute ischemic stroke: Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 28:957-960, 1997.
10. Levy DE, Brott TG, Haley EC Jr, Marler JR, Sheppard GL, Barsan W, Broderick JP: Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 25:291-297, 1994.
11. Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y, Kitano K, Tsutsumi A, Yamadori A: Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 42:976-982, 1992.
12. Nakano S, Yokogami K, Ohta H, Goya T, Wakisaka S: Direct percutaneous transluminal angioplasty for acute embolic middle cerebral artery occlusion: Report of two cases. Angiology 6:254-256, 1997.
13. Nakano S, Yokogami K, Ohta H, Yano T, Ohnishi T: Direct percutaneous transluminal angioplasty for acute middle cerebral artery occlusion. AJNR Am J Neuroradiol 19:767-772, 1998.
14. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587, 1995.
15. Theron J, Courtheoux P, Casasco A, Alachkar F, Notari F, Ganem F, Maiza D: Local intraarterial fibrinolysis in the carotid territory. AJNR Am J Neuroradiol 10:753-765, 1989.
16. von Kummer R, Hacke W: Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 23:646-652, 1992.
17. Wardlaw JM, Warlow CP: Thrombolysis in acute ischemic stroke: Does it work? Stroke 23:1826-1839, 1992.
18. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ, and the rt-PA Acute Stroke Study Group: Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 14:3-13, 1993.
19. Yamaguchi T, Hayakawa T, Kikuchi H, for the Japanese Thrombolysis Study Group: Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke. Cerebrovasc Dis 3:269-272, 1993.
20. Yokogami K, Nakano S, Ohta H, Goya T, Wakisaka S: Prediction of hemorrhagic complications after thrombolytic therapy for middle cerebral artery occlusion: Value of pre-and post-therapeutic computed tomographic findings and angiographic occlusive site. Neurosurgery 39:1102-1107, 1996.